Prospective Multi-centre Study of Prognostic Factors in Castration Resistant PROState Cancer Treated With doceTaxel or Cabazitaxel
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Cabazitaxel (Primary) ; Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PROSTAC
- 01 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Aug 2018.
- 10 Jun 2017 Biomarkers information updated
- 07 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2018.